From the Department of Pediatrics, Keio University School of Medicine,
Tokyo, Japan.
Correspondence to Midori Awazu, MD, Department of Pediatrics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan. E-mail awazu{at}mc.med.keio.ac.jp
AbstractTrapidil, an
antiplatelet drug, has been shown to reduce restenosis
after angioplasty. It exerts its action, at least in part, by
inhibiting vascular smooth muscle cell proliferation, antagonizing
platelet-derived growth factor (PDGF). We examined its site of
action on PDGF cellular signaling. Exposure of cultured rat vascular
smooth muscle cells to increasing concentrations of trapidil for 18
hours resulted in a dose-dependent reduction in PDGF-BBstimulated
[3H] thymidine incorporation. Trapidil (400 µg/mL)
increased PDGF ß-receptor protein by 28±8%, whereas PDGF-induced
tyrosine phosphorylation of PDGF ß-receptor remained
unchanged. PDGF-induced tyrosine phosphorylation of
phospholipase C
© 1998 American Heart Association, Inc.
Scientific Contributions
Trapidil Inhibits Platelet-Derived Growth FactorStimulated Mitogen-Activated Protein Kinase Cascade
, the p85 regulatory subunit of phosphatidyl-inositol
3 kinase, Ras GTPaseactivating protein, and an adaptor molecule Shc
were also not altered. On the other hand, trapidil inhibited
PDGF-stimulated mitogen-activated protein kinase (MAP kinase)
activity by 35±7% at 10 minutes and by 32±10% at 6 hours.
Activation of Raf-1, an upstream activator of MAP kinase,
by PDGF was also attenuated by trapidil. Moreover, protein content of
MAP kinase phosphatase-1, which inactivates MAP kinase, was
elevated in trapidil-treated cells. These actions of trapidil may be
mediated by cAMP. Thus, there was a 1.9-fold increase in cellular cAMP
generation in trapidil-treated cells. The present results
demonstrate that trapidil antagonizes PDGF-induced mitogenesis and MAP
kinase activation in vascular smooth muscle cells, probably
through cAMP.
Key Words: trapidil growth factors, platelet-derived restenosis kinases mitogenesis cyclic AMP
This article has been cited by other articles:
![]() |
C. V. Garat, D. Fankell, P. F. Erickson, J. E.-B. Reusch, N. N. Bauer, I. F. McMurtry, and D. J. Klemm Platelet-Derived Growth Factor BB Induces Nuclear Export and Proteasomal Degradation of CREB via Phosphatidylinositol 3-Kinase/Akt Signaling in Pulmonary Artery Smooth Muscle Cells. Mol. Cell. Biol., July 1, 2006; 26(13): 4934 - 4948. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Klemm, P. A. Watson, M. G. Frid, E. C. Dempsey, J. Schaack, L. A. Colton, A. Nesterova, K. R. Stenmark, and J. E.-B. Reusch cAMP Response Element-binding Protein Content Is a Molecular Determinant of Smooth Muscle Cell Proliferation and Migration J. Biol. Chem., November 30, 2001; 276(49): 46132 - 46141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goetze, X.-P. Xi, Y. Kawano, H. Kawano, E. Fleck, W. A. Hsueh, and R. E. Law TNF-{alpha}–Induced Migration of Vascular Smooth Muscle Cells Is MAPK Dependent Hypertension, January 1, 1999; 33(1): 183 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bönisch, A.-A. Weber, M. Wittpoth, M. Osinski, and K. Schrör Antimitogenic Effects of Trapidil In Coronary Artery Smooth Muscle Cells by Direct Activation of Protein Kinase A Mol. Pharmacol., August 1, 1998; 54(2): 241 - 248. [Abstract] [Full Text] |
||||
![]() |
S. Goetze, U. Kintscher, H. Kawano, Y. Kawano, S. Wakino, E. Fleck, W. A. Hsueh, and R. E. Law Tumor Necrosis Factor alpha Inhibits Insulin-induced Mitogenic Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., June 9, 2000; 275(24): 18279 - 18283. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |